Ellipsys Vascular Access System Post Market Surveillance (PS) Study
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04484220. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Ellipsys Vascular Access System Post Market Surveillance (PS) Study PS200001 Reference DEN170004
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The proposed clinical study is a prospective, non-randomized, multi-center, single-arm, observational, post-market surveillance (PS) study of the Ellipsys Vascular Access System in subjects eligible for arteriovenous (AV) fistula.
Study identification
- NCT ID
- NCT04484220
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 142 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 13, 2021 (Actual)
- Primary completion
- Mar 31, 2025 (Actual)
- Completion
- Mar 31, 2025 (Actual)
- Last update posted
- Jun 1, 2026
2021 – 2025
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nephrology Associates Access Center | Riverside | California | 92501 | — |
| Yale University | New Haven | Connecticut | 06510 | — |
| Azura Vascular Care, Jacksonville | Jacksonville | Florida | 32218 | — |
| Coastal Vascular and Interventional, PLLC | Pensacola | Florida | 32504 | — |
| Rush University Medical Center | Chicago | Illinois | 60607 | — |
| The Vascular Care Group | Hyannis | Massachusetts | 022601 | — |
| Nephrology Kidney Disease Hypertension Center | Las Vegas | Nevada | 89128 | — |
| Staten Island Hospital | Staten Island | New York | 10305 | — |
| University of Pittsburg Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| STAR Vascular Access Center | San Antonio | Texas | 78207 | — |
| San Antonio Kidney Disease Center | San Antonio | Texas | 78216 | — |
| Richmond Vascular Center | North Chesterfield | Virginia | 23236 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04484220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 1, 2026 · Synced Nov 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.